Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Long-Term Debt Issuances (2022)

Cue Biopharma (CUE) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$5.3 million as the latest value for Q4 2022.

  • Quarterly Long-Term Debt Issuances changed N/A to -$5.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$5.3 million through Sep 2023, down 153.0% year-over-year, with the annual reading at $18000.0 for FY2024, N/A changed from the prior year.
  • Long-Term Debt Issuances hit -$5.3 million in Q4 2022 for Cue Biopharma, down from $10.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $10.0 million in Q1 2022 to a low of -$5.3 million in Q4 2022.